癌におけるミトコンドリア・ホメオスタシス:機能と標的治療法

Lihan Wei¹, Boxiang Hong¹, Xiawei Zhang¹

¹School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, 325000, China.

Critical reviews in oncology/hematology

|August 23, 2025

まとめ

ミトコンドリア・ホメオスタシスの障害は癌の成長を促しますこれらの変異したミトコンドリアを標的とした治療は有効な腫瘍治療と臨床管理の新しい有望な戦略です

科学分野:

腫瘍学
ミトコンドリア生物学
癌代謝

背景:

ミトコンドリア・ホメオスタシスは腫瘍細胞で頻繁に乱れ,腫瘍発生と進行を促します.
腫瘍細胞のミトコンドリアは,増加した代謝需要を満たすために,変異,増殖,分裂を経験します.
この障害は腫瘍細胞の増殖,侵入,転移,エネルギー代謝,および酸化還元バランスに影響します.

研究の目的:

癌におけるミトコンドリア・ホメオスタティック・ディスレギュレーションの理解における最近の進歩をレビューする.
腫瘍治療における腫瘍性ミトコンドリアを標的とした治療の可能性について議論する.

主な方法:

癌におけるミトコンドリア機能障害に関する現在の研究の文献レビュー.
腫瘍形成におけるミトコンドリア・ホメオスタシスの役割の分析.
ミトコンドリアを標的とする医薬品の臨床前および臨床試験の探索

主要な成果:

ミトコンドリアの構造と機能の重大な変化は,腫瘍細胞の特徴です.
ミトコンドリア・ホメオスタシスの不調は癌の進行と転移の主要な要因です
ミトコンドリアを標的とした治療は,新しいがん治療戦略の可能性を示しています.

結論:

腫瘍性ミトコンドリアを標的とした治療は癌管理の有望な治療法です
ミトコンドリアを標的とする薬剤の研究は腫瘍治療の進歩につながるかもしれません

キーワード:

ミトコンドリアミトコンドリア動態ミトスタシス標的型療法腫瘍

さらに関連する動画

07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

7.0K

11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

2.8K

関連する概念動画

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

03:03

mTOR Signaling and Cancer Progression

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

3.9K

02:40

Cancer Stem Cells and Tumor Maintenance

5.0K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

5.0K

01:45

Mitochondrial Membranes

12.3K

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...